Singapore, Singapore · Founded 2007 · Privately Held (backing)
Developer of a robotic prostate biopsy and treatment system designed for improved clinical outcomes. Biobot Surgical is based in Singapore, Singapore and was founded in 2007. Its last reported valuation was $54.3 million in Mar 2024. It has raised $38.7 million.
Last reported valuation
$54.3M
Oct 2026
Priced at
—
Total raised
$38.7M
Last round
—
Cap table — not yet on record
Biobot Surgical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biobot Surgical with a free account
·The complete investor list: 16 names
·Watch Biobot Surgical: the Monday email on marks, rounds and moves
